SCHEMBL7957657

SCHEMBL7957657

CCOC(=O)CCCN1CCC(c2cccc(Cl)c2Cl)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 5/20 0.49
MAPT P10636 2/20 0.48
KDM4E B2RXH2 5/20 0.48
ALDH1A1 P00352 3/20 0.48
TDP1 Q9NUW8 2/20 0.48
TSHR P16473 3/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
LMNA P02545 2/20 0.47
POLB P06746 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HTR1A P08908 1/20 0.46
HTR2A P28223 1/20 0.46
HTR2C P28335 1/20 0.46
HTR2B P41595 1/20 0.46
NPY1R P25929 1/20 0.46
HSD17B10 Q99714 3/20 0.45
HTR4 Q13639 1/20 0.45
CYP2C9 P11712 3/20 0.43
MEN1 O00255 2/20 0.43
CYP1A2 P05177 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7961467 0.91 HTR4 (0.48) DRD2MAPTKDM4EALDH1A1TDP1
SCHEMBL7960244 0.82 DRD2 (0.62) DRD2MAPTKDM4EALDH1A1NPY1R
SCHEMBL7961389 0.82 NPY1R (0.50) DRD2KDM4EALDH1A1L3MBTL1LMNA
SCHEMBL7957636 0.81 NPY1R (0.47) DRD2KDM4EALDH1A1TDP1TSHR
SCHEMBL7963919 0.80 HSD17B10 (0.53) DRD2KDM4ENPY1RHSD17B10
SCHEMBL1491174 0.80 DRD2 (0.65) DRD2HTR1AHTR2ACNR1
SCHEMBL7949576 0.80 DRD2 (0.48) DRD2ALDH1A1LMNAPOLBHTR1A
SCHEMBL7949172 0.79 DRD2 (0.61) DRD2HTR1AHTR2A
SCHEMBL10595036 0.79 SLC18A3 (0.61) DRD2TSHRHTR1AHTR2AHTR4
SCHEMBL7961109 0.78 ALDH1A1 (0.42) DRD2MAPTKDM4EALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed